ask="N/A"
ask_size="N/A"
average_daily_volume="1330440"
bid="37.50"
bid_size="600"
book_value="11.83"
change="+0.46"
change_from_200_day_moving_average="-12.94"
change_from_50_day_moving_average="0.10"
change_from_52_week_high="-39.66"
change_From_52_week_low="9.07"
change_in_percent="+1.15%"
close="40.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.82"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="40.50"
high_52_weeks="80.11"
last_trade_date="2/1/2017"
last_trade_price="40.45"
last_trade_size="49829"
last_trade_time="4:00pm"
low="39.01"
low_52_weeks="31.38"
market_capitalization="3.47B"
moving_average_200_day="53.39"
moving_average_50_day="40.35"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="63.57"
open="40.07"
pe_ratio="N/A"
peg_ratio="-0.18"
percent_change_from_200_day_moving_average="-24.23%"
percent_change_from_50_day_moving_average="+0.26%"
percent_change_from_52_week_high="-49.51%"
percent_change_from_52_week_low="+28.90%"
previous_close="39.99"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.38"
price_per_sales="92.11"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="8.69"
stock_exchange="NMS"
symbol="ALNY"
volume="795014"
weeks_range_52="31.38 - 80.11"
